These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7910656)

  • 41. Contrast sensitivity function in patients with beta-thalassemia major.
    Gartaganis SP; Zoumbos N; Koliopoulos JX; Mela EK
    Acta Ophthalmol Scand; 2000 Oct; 78(5):512-5. PubMed ID: 11037904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pituitary somatotropic and corticotropic function in patients with beta-thalassemia on iron chelation therapy.
    Tolis G; Politis C; Kontopoulou I; Poulatzas N; Rigas G; Saridakis C; Athanasiou V; Mortoglou A; Malachtari S; Ling N
    Birth Defects Orig Artic Ser; 1987; 23(5A):449-52. PubMed ID: 3120817
    [No Abstract]   [Full Text] [Related]  

  • 43. [Certain neuroendocrine factors of regulation in children with somatogenic and hypophyseal nanism].
    Ozerova MR; Osinskaia VO; Kurbanov T; Anishchuk VP; Markova IS
    Pediatriia; 1975 Jul; (7):16-9. PubMed ID: 1215082
    [No Abstract]   [Full Text] [Related]  

  • 44. [Growth hormone secretion and somatostatin].
    Wakabayashi K; Miki N; Miyazawa Y; Kanda K; Koezuka N
    Horumon To Rinsho; 1978 Jun; 26(6):524-8. PubMed ID: 688653
    [No Abstract]   [Full Text] [Related]  

  • 45. Studies of growth hormone secretion in children: normal, hypopituitary and constitutionally delayed.
    Frohman LA; Aceto T; MacGillivray MH
    J Clin Endocrinol Metab; 1967 Oct; 27(10):1409-17. PubMed ID: 6057822
    [No Abstract]   [Full Text] [Related]  

  • 46. Critical appraisal of growth retardation and pubertal disturbances in thalassemia.
    Chatterjee R; Bajoria R
    Ann N Y Acad Sci; 2010 Aug; 1202():100-14. PubMed ID: 20712780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Urgent cerebral pathology in hypophyseal nanism].
    Erokhina LG; Chekneva NS; Stakhovskaia LV; Bogach ND
    Sov Med; 1991; (5):82-5. PubMed ID: 1876940
    [No Abstract]   [Full Text] [Related]  

  • 48. Current growth patterns in children and adolescents with thalassemia major.
    Origa R; Danjou F; Orecchia V; Zappu A; Dessì C; Foschini ML; Leoni GB; Moi P; Morittu M; Demurtas A; Loche S
    Blood; 2016 Nov; 128(21):2580-2582. PubMed ID: 27737888
    [No Abstract]   [Full Text] [Related]  

  • 49. [On dyscerebral dwarfism. Clinical contribution].
    Guzzetta F
    Minerva Pediatr; 1967 May; 19(19):932-40. PubMed ID: 5607570
    [No Abstract]   [Full Text] [Related]  

  • 50. Reproductive health in female patients with beta-thalassemia major.
    Protonotariou AA; Tolis GJ
    Ann N Y Acad Sci; 2000; 900():119-24. PubMed ID: 10818398
    [No Abstract]   [Full Text] [Related]  

  • 51. [Dwarfism and secretion of human GH].
    de Matteis F
    Minerva Pediatr; 1976 May; 28(18):1095-101. PubMed ID: 1012184
    [No Abstract]   [Full Text] [Related]  

  • 52. Body composition in homozygous beta-thalassemia.
    Kalef-Ezra J; Zibis A; Chaliassos N; Hatzikonstantinou I; Karantanas A
    Ann N Y Acad Sci; 2000 May; 904():621-4. PubMed ID: 10865816
    [No Abstract]   [Full Text] [Related]  

  • 53. Human growth hormone.
    Hamilton W
    Scott Med J; 1975 Sep; 20(5):197-200. PubMed ID: 772806
    [No Abstract]   [Full Text] [Related]  

  • 54. Late puberty, retarded growth and reversible hyposomatotropinism (psychosocial dwarfism).
    Money J; Wolff G
    Adolescence; 1974; 9(33):121-34. PubMed ID: 4440530
    [No Abstract]   [Full Text] [Related]  

  • 55. Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major.
    Grundy RG; Woods KA; Savage MO; Evans JP
    Arch Dis Child; 1994 Aug; 71(2):128-32. PubMed ID: 7944532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of human growth hormone on long term growth of 8 persons with hypophyseal dwarfism].
    Elsair J
    Tunis Med; 1967; 45(3):187-8 passim. PubMed ID: 5622121
    [No Abstract]   [Full Text] [Related]  

  • 57. [Behavior of somatotropin secretion in chronic liver diseases].
    Giordano G; Marugo M; Minuto F; Barreca T
    Arch Maragliano Patol Clin; 1971; 27(3):175-93. PubMed ID: 5172718
    [No Abstract]   [Full Text] [Related]  

  • 58. [Auxological studies of 50 children with beta-thalassemia major].
    Agnello D; Malizia R; Scalisi D; Pitruzzella E; Masseria R
    Pediatria (Napoli); 1981; 89(2):207-17. PubMed ID: 7312490
    [No Abstract]   [Full Text] [Related]  

  • 59. [Role of somatostatin in the regulation of GH in rats (author's transl)].
    Wakabayashi I
    Horumon To Rinsho; 1979 May; 27(5):465-71. PubMed ID: 455755
    [No Abstract]   [Full Text] [Related]  

  • 60. Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy.
    Cianciulli P; Sollecito D; Sorrentino F; Forte L; Gilardi E; Massa A; Papa G; Carta S
    Kidney Int; 1994 Aug; 46(2):467-70. PubMed ID: 7967359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.